Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2025 Aug 29;16:1646824. doi: 10.3389/fphar.2025.1646824

Correction: Efficacy and safety of oral Chinese medicine combined with chemotherapy: a systematic review and network meta-analysis

Yuqi Ma 1, Jia Li 1, Liyun Liu 1,*,†, Tao Shen 1,*,†
PMCID: PMC12426422  PMID: 40949151

The figure graphics and captions for Figures 2, 3 were reversed in the published article. Figure 2 was incorrectly linked to the Figure 3 graphic, with the caption ‘Network graphs of outcomes. (A) Objective response rate. (B) TP therapy’, while Figure 3 was incorrectly linked to the Figure 2 graphic, with the caption ‘Risk of Bias Summary’. The in-text citations were correct. The graphic and caption order have now been corrected.

FIGURE 2.

A risk assessment table evaluates studies from 2003 to 2023 across five categories: randomization process, deviations from intended interventions, missing outcome data, measurement of the outcome, and selection of the reported result. Each category is marked with symbols: green plus (low risk), yellow question mark (some concerns), or red minus (high risk). The overall assessment is indicated by the yellow exclamation mark for most cases, suggesting some concerns.

Risk of bias summary.

FIGURE 3.

Two network diagrams labeled A and B. Diagram A shows a central node labeled "Cisplatin" connected to nodes "JFK+Cisplatin," "TFS+Cisplatin," "HS+Cisplatin," "XK+Cisplatin," and "TGT+Cisplatin" with varying line thickness. Diagram B displays a central node labeled "Cisplatin/Paclitaxel" connected to nodes "HS+Cisplatin/Paclitaxel," "FZ+Cisplatin/Paclitaxel," "JFK+Cisplatin/Paclitaxel," and "TGT+Cisplatin/Paclitaxel." Both diagrams use blue nodes and black lines.

Network graphs of outcomes. (A) Objective response rate. (B) TP therapy.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES